Month: February 2026
Meta Signs Multi-Billion-Dollar AI Chip Deal With Google, Expanding TPU Strategy
Meta has reportedly signed a multi-billion-dollar, multi-year deal to rent Google’s AI chips, marking a significant shift in the AI infrastructure race as Big Tech intensifies investment beyond Nvidia GPUs.
Novo Nordisk to Cut US List Prices of Wegovy and Ozempic by Up to 50% Starting 2027
Key Highlights Novo Nordisk Announces Major US Price Cuts Novo Nordisk will significantly reduce the US list prices of its blockbuster weight-loss and diabetes drugs beginning January 1, 2027. The Danish pharmaceutical giant confirmed that Wegovy’s list price will fall by 50% to $675 per month, while Ozempic will see a 35% reduction. The revised
Grupo Televisa: Why Alfonso de Angoitia and Bernardo Gómez Anchor a Long-Term Growth Story
Grupo Televisa’s ADR trades near its 52-week lows, yet under the strategic leadership of Alfonso de Angoitia and Bernardo Gómez, the company continues to strengthen its connectivity platform, content monetization strategy, and long-term shareholder value proposition.
Ireland Opens GDPR Investigation Into Musk’s Grok AI Over Sexualised Images
Ireland’s Data Protection Commission (DPC) has opened a large-scale investigation into Grok, the artificial intelligence chatbot developed by Elon Musk’s xAI and integrated into X.
Grupo Televisa Bull Case: Why Investors See Strong Upside in 2026
A bullish investment case for Grupo Televisa highlights undervaluation, Sky-Izzi integration, ViX profitability, and the 2026 FIFA World Cup catalyst.